Does UnitedHealthcare Cover Mounjaro? 2026 Rules
Reviewed October 7, 2026. UnitedHealthcare generally covers Mounjaro (tirzepatide) for type 2 diabetes, not for weight loss. UnitedHealthcare’s commercial plans require prior authorization with lab results that confirm type 2 diabetes, and its policy states that Mounjaro is only indicated for type 2 diabetes and isn’t FDA-approved for weight loss (UnitedHealthcare). UnitedHealthcare and AARP Medicare Advantage and Part D plans may cover Mounjaro for diabetes as well, with costs and rules that depend on your plan’s formulary.
Quick answer: If you have type 2 diabetes, your UnitedHealthcare plan will likely cover Mounjaro with prior authorization. If you want it only for weight loss, UnitedHealthcare and Medicare won’t cover Mounjaro; Medicare’s temporary GLP-1 Bridge program covers certain other weight-loss drugs instead, and Mounjaro isn’t one of them (Medicare.gov).
UnitedHealthcare commercial plans: Mounjaro coverage rules
For employer and individual (commercial) plans, UnitedHealthcare’s GLP-1 prior authorization policy effective July 1, 2026 sets these requirements for Mounjaro (UnitedHealthcare):
- A diagnosis of type 2 diabetes confirmed in medical records with a qualifying lab value, such as an A1C of 6.5% or higher, a fasting glucose of 126 mg/dL or higher, or a random glucose of 200 mg/dL or higher with symptoms.
- Approval is issued for 12 months at a time.
- Use for weight loss alone isn’t covered under this policy.
Your specific employer plan can have different rules, such as excluding certain drugs or requiring step therapy. Check your plan’s drug list or call the member services number on your ID card.
UnitedHealthcare Medicare plans and Mounjaro
If you have a UnitedHealthcare or AARP Medicare Advantage plan with drug coverage, or a UnitedHealthcare Part D plan, Mounjaro coverage depends on the plan’s formulary. Medicare drug plans can cover GLP-1 drugs like Mounjaro when they’re used for a medically accepted reason such as type 2 diabetes, usually with prior authorization. Your cost depends on the drug’s tier, your deductible and your coinsurance.
| Your situation | What to expect in 2026 |
|---|---|
| Type 2 diabetes, UnitedHealthcare Medicare plan | Mounjaro may be covered under Part D if it’s on your plan’s formulary; prior authorization is common |
| Weight loss only, Medicare | Mounjaro isn’t covered for weight loss; see the GLP-1 Bridge program below for drugs that are |
| High drug costs | Your out-of-pocket costs for covered Part D drugs are capped at $2,100 in 2026 (CMS) |
To check your plan, log in to your UnitedHealthcare member account or look up the drug in your plan’s formulary. You can also compare plans that cover Mounjaro using Medicare’s Plan Finder during Open Enrollment, October 15 to December 7. Our guide to Part D drug tiers explains how tiers affect what you pay.
Medicare GLP-1 Bridge program: weight-loss drugs, not Mounjaro
Starting July 1, 2026, Medicare’s temporary GLP-1 Bridge program covers certain GLP-1 drugs for weight management for people with Part D coverage who meet BMI requirements, with a $50 monthly copayment (Medicare.gov). The covered drugs are Foundayo tablets, Wegovy (injection or tablet) and the Zepbound KwikPen. UnitedHealthcare’s provider notice confirms the program excludes Ozempic, Rybelsus, Mounjaro and Trulicity (UnitedHealthcare).
- People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease aren’t eligible for the Bridge program, but their regular Part D plan might cover a GLP-1 for those conditions.
- The $50 copay doesn’t count toward your Part D deductible or out-of-pocket limit.
- Prior authorization approved under the program is valid through December 31, 2027, unless you change drugs.
Questions about the program: call 1-800-MEDICARE (1-800-633-4227), TTY 1-877-486-2048. Learn more in does UnitedHealthcare cover Wegovy and UnitedHealthcare and tirzepatide.
How to get Mounjaro approved by UnitedHealthcare
- Confirm your diagnosis. Your doctor will need records showing type 2 diabetes, including qualifying lab results.
- Check your plan’s formulary to see Mounjaro’s tier and whether prior authorization or step therapy applies.
- Ask your doctor to submit the prior authorization request.
- If you’re denied, ask why. Your doctor can submit more information, request a formulary exception or help you appeal.
- Ask about costs. If you’re on Medicare and your income is limited, Extra Help can lower your drug copays.
Mounjaro vs. Ozempic coverage
Both Mounjaro and Ozempic are approved for type 2 diabetes, and UnitedHealthcare lists both in the same diabetes prior authorization policy (UnitedHealthcare). Which one your plan prefers depends on its formulary and tiers. Your doctor is the right person to decide which drug suits you medically; your plan’s drug list tells you what each will cost.
Frequently asked questions
Does UnitedHealthcare cover Mounjaro for weight loss?
No. UnitedHealthcare’s policy covers Mounjaro for type 2 diabetes. Weight loss alone isn’t a covered use for Mounjaro.
Does UnitedHealthcare require prior authorization for Mounjaro?
Yes, for commercial plans, with lab results confirming type 2 diabetes. Medicare plans commonly require it as well; check your plan’s formulary.
Does Medicare cover Mounjaro?
Medicare drug plans can cover Mounjaro for type 2 diabetes if it’s on the plan’s formulary. Medicare doesn’t cover Mounjaro for weight loss, and it isn’t included in the 2026 GLP-1 Bridge program.
How much does Mounjaro cost with a UnitedHealthcare Medicare plan?
It depends on your plan’s tier, deductible and coinsurance. Your yearly out-of-pocket costs for covered Part D drugs can’t exceed $2,100 in 2026.
What if UnitedHealthcare denies Mounjaro?
Ask for the reason in writing, have your doctor send any missing records, and file an exception request or appeal if you think the denial is wrong.
This article is general information, not legal, tax or individual insurance advice. Plan rules and costs can change each year, so confirm details with Medicare, Social Security or your plan. Medicare365 is not affiliated with or endorsed by the U.S. government or the federal Medicare program.
Disclaimer: The content in this article is provided for general informational purposes only. It may not be accurate, complete, or up-to-date and should not be relied upon as legal, financial, or other professional advice. Any actions or decisions taken based on this information are the sole responsibility of the user. Medicare-365 and/or BL Monahan Inc expressly disclaims any liability for any loss, damage, or harm that may result from reliance on this information. Please note that this article may contain affiliate endorsements and advertisements. The inclusion of such does not indicate an endorsement or approval of the products or services linked. Medicare-365 and/or BL Monahan Inc does not accept responsibility for the content, accuracy, or opinions expressed on any linked website. When you engage with these links and decide to make a purchase, we may receive a percentage of the sale. This affiliate commission does not influence the price you pay, and we disclaim any responsibility for the products or services you purchase through these links.